MedySapiens

Private

SeoulHealthcare & Life Scienceshttps://medysapiens.com/en

Last Round

Series B

Jul 1, 2026

Total Funding Raised

$7M

Company Overview

MedySapiens is a biotechnology company that develops AI-powered diagnostic solutions for the early detection of rare genetic diseases in newborns.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical AI, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

genomic data analysisrare disease diagnosisbioinformaticsneonatal diagnosticsclinical decision supportprecision medicinenext-generation sequencingNGSgenetic testinggenomics AImedical AIvariant interpretationclinical genomicsgenomic medicinedigital health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MedySapiens Comps

Public and private peers based on sector, stage, and business model.

MedySapiens comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

MedySapiens Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series B	Jul 1, 2026
Series A	Feb 1, 2022
Pre Seed	Aug 27, 2019
Seed	Oct 26, 2018

View all Funding Rounds

Key People

Founding team and executive leadership

Taehyuk Kwon

COO

Executive Team

MedySapiens Investors

Notable investors and investment history

MedySapiens investors
Investor	Rounds
L&S Venture Capital	Series A
Vision Creator	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Oct 10, 2024
Monthly visitors grew 103% MoM.

View all signals

MedySapiens Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

MedySapiens Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MedySapiens's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul

Employee Range13

Year Founded2016

Last FundingJul 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.